Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2593–2616 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Smoking Cessation, Harm Reduction
Interventions: Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product, NJOY e-cigarette, on!; Drug · Other
Lead sponsor: Rose Research Center, LLC; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Charlotte, North Carolina • Raleigh, North Carolina

Conditions: Herpes Labialis
Interventions: acyclovir/hydrocortisone cream; Drug
Lead sponsor: Meda Pharmaceuticals; Industry
Eligibility: 6 Years to 11 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 10
States / cities: Los Angeles, California • Opa-locka, Florida • West Palm Beach, Florida + 7 more

Conditions: Contact Dermatitis
Interventions: AI algorithm to evaluate photographs of skin test patch regions, Allergen Patch; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Early-Stage Breast Carcinoma
Interventions: Cyrcadia CBR™ device placement for abnormality screening; Device
Lead sponsor: Cyrcadia Health; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Mountain View, California • Columbus, Ohio

Conditions: Colon Cancer, Liver Tumors
Interventions: blood draws, colectomy or hepatectomy, Fibroscan test; Other · Procedure · Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 4
States / cities: Basking Ridge, New Jersey • Commack, New York • Harrison, New York + 1 more

Conditions: Breast Neoplasms
Interventions: MagneMarker; Device
Lead sponsor: Antonios Likourezos; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Choroidal Neovascularization, Macular Degeneration
Interventions: verteporfin, ranibizumab, dexamethasone; Drug
Lead sponsor: QLT Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 21
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 18 more

Conditions: Tobacco Smoking
Interventions: Motivational Interviewing, Nicotine Replacement Therapy Sampling, Referral Only; Behavioral · Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 65 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Small-cell Lung Cancer
Interventions: Carboplatin, Etoposide, Atezolizumab, Stereotactic Body Radiation Therapy (SBRT); Drug · Radiation
Lead sponsor: Brian Henick, MD; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Knee Osteoarthritis
Interventions: CNTX-4975-05, Qutenza, Lidocaine (without epinephrine); Drug
Lead sponsor: Centrexion Therapeutics; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cardiovascular Disease
Interventions: Active Clonidine, Placebo Clonidine, Active ASA, Placebo ASA; Drug
Lead sponsor: Hamilton Health Sciences Corporation; Other
Eligibility: 45 Years and older
Enrollment: 10,010 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Lung Cancer
Interventions: Image guided Video-Assisted Thoracic Surgery (VATS) resection, Video-Assisted Thoracic Surgery; Device · Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: In-Stent Restenosis
Interventions: AGENT DCB 40 mm; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 11
States / cities: Tucson, Arizona • Los Angeles, California • Atlanta, Georgia + 8 more

Conditions: Peripheral Vascular Disease
Interventions: Paclitaxel; Drug
Lead sponsor: Patrick Kelly; Other
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Skin Irritation
Interventions: Diltiazem Hydrochloride 2% Cream, Vehicle Cream, 0.1% solution o sodium lauryl sulfate (SLS), Saline 0.9%; Drug
Lead sponsor: Ventrus Biosciences, Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Paramus, New Jersey

Conditions: Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma, Pseudoexfoliation Glaucoma, Pigmentary Glaucoma, Traumatic Glaucoma, Uveitic Glaucoma, Neovascular Glaucoma
Interventions: Molteno 3 glaucoma drainage shunt; Procedure
Lead sponsor: Wills Eye; Other
Eligibility: 19 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Smoking
Interventions: Nicotine Patch, SPECTRUM Nicotine Research Cigarettes (.03 mg), Behavioral Activation, Supportive Counseling; Drug · Behavioral
Lead sponsor: Maggie M Sweitzer, PhD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Atopic Dermatitis
Interventions: Lebrikizumab, Placebo, TCS Cream; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 16
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 13 more

Conditions: Arteriovenous Fistula, Arteriovenous Graft, Fistula, Arterial Occlusive Diseases
Interventions: FLEX Vessel Prep System; Device
Lead sponsor: VentureMed Group Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 4
States / cities: Miami, Florida • New Brighton, Minnesota • Orangeburg, South Carolina + 1 more

Conditions: Kidney Cancer
Interventions: Perflutren lipid microsphere, Sulfur hexafluoride lipid microspheres; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Major Depressive Disorder
Interventions: Nicotine; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Amblyopia
Interventions: Eye patch; Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 7 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Advanced Solid Tumor
Interventions: STX-001, Keytruda®; Biological
Lead sponsor: Strand Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 6
States / cities: Scottsdale, Arizona • Beverly Hills, California • Cleveland, Ohio + 3 more

Conditions: Prevention of Nausea Associated With Motion Sickness, Treatment of Nausea Associated With Motion Sickness
Interventions: Scopolamine Transdermal Patch [Transderm Scop], Scopolamine, Placebo Patch, Placebo Gel; Drug
Lead sponsor: Naval Aeromedical Research Unit, Dayton; Federal
Eligibility: 18 Years to 59 Years
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Dayton, Ohio

Search by objective public record fields.

Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

DermAI to Evaluate Human Factor of Testing

Circadian Thermal Sensing to Detect Breast Disease

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

A Trial of a New Magnetic Breast Marking Clip

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Tobacco and Socioeconomic Disadvantage

Liver Directed RT + Chemo-immunotherapy for ES-SCLC

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

PeriOperative ISchemic Evaluation-2 Trial

Image Guided VATS vs. VATS Resection

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort

Effects of Paclitaxel on Intimal Hyperplasia

A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design

Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube

Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation

A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis

FLEX FIRST Registry Research Protocol

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)

Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels